An international team of researchers, led by scientists at UC San Diego, report that a gene therapy that inhibits targeted nerve cell signaling effectively reduced neuropathic pain with no detectable side effects in mice with spinal cord or peripheral nerve injuries.
Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.
On Saturday, May 14 the 43rd Annual Alumni Awards will honor eight extraordinary individuals who are innovating new possibilities around the globe, and our Wavemakers—exceptional legacy leaders, actively creatin… […]
With holidays and winter weather approaching, concerns about COVID-19 infections are on the rise. But despite increasing access to vaccines and booster shots, one group continues to show low vaccination rates. … […]